BGI Group has been at the forefront in the fight against COVID-19. Starting from building a lab in Wuhan, sequencing the first 2019-nCoV virus genome to supplying extraction kits and automation for over 1,000,000 tests in more than 60 countries.
MGI focuses on building core tools and technology to lead life science through intelligent innovation. MGI and Paragon Genomics are joining forces to present a live webinar that describes MGI and Paragon Genomics workflows and total solutions for Metascriptomics and High Throughput Amplicon based sequencing for COVID-19 surveillance. The total solutions include one-stop nucleic acid extraction and high-throughput sequencing.
If you have any questions, you can send an email to: